SCHEMBL27830004

SCHEMBL27830004

CC(C)(C)C(=O)ON1CCC(n2cc(-c3cnc(N)c(-c4nc5ccccc5o4)c3)cn2)CC1

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 0.76
KCNH2 Q12809 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2385009 0.88 MET (0.83) METKCNH2
SCHEMBL27848452 0.88 AXL (0.74) METKCNH2
SCHEMBL28790970 0.86 MET (0.56) METKCNH2
SCHEMBL28790972 0.85 MET (0.57) MET
SCHEMBL27829990 0.85 MET (0.56) METKCNH2
SCHEMBL2385279 0.85 MET (0.80) METKCNH2
SCHEMBL2384836 0.84 MET (1.00) METKCNH2
SCHEMBL2386679 0.83 MET (1.00) METKCNH2
SCHEMBL27829963 0.83 MET (0.52) METKCNH2
SCHEMBL2385934 0.83 MET (0.76) METKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101910158-A Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders ASTRAZENECA AB 2010-12-08 CN disclosed